Adding the experimental anti-CD38 therapy felzartamab reduced the risk of disease progression among people with hard-to-treat myeloma in a Phase 3 clinical trial conducted…

A large U.S. clinical trial is now underway to test a newly approved pancreatic cancer drug in combination with an experimental therapy in people…

Multiple myeloma grabbed one last headline as we closed out Blood Cancer Awareness Month last week. On Sept. 29, Lady A singer…